image
Healthcare - Medical - Instruments & Supplies - NYSE - US
$ 20.57
2.44 %
$ 3.54 B
Market Cap
-2.66
P/E
1. INTRINSIC VALUE

Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, and Orascoptic brands; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Insignia, AOA, and Spark brands.[ Read More ]

The intrinsic value of one NVST stock under the base case scenario is HIDDEN Compared to the current market price of 20.6 USD, Envista Holdings Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart NVST

image
FINANCIALS
2.57 B REVENUE
-0.10%
31.5 M OPERATING INCOME
-90.13%
-100 M NET INCOME
-41.22%
276 M OPERATING CASH FLOW
50.90%
-62.4 M INVESTING CASH FLOW
90.51%
119 M FINANCING CASH FLOW
851.20%
601 M REVENUE
-5.07%
20.9 M OPERATING INCOME
231.75%
8.2 M NET INCOME
100.71%
70.7 M OPERATING CASH FLOW
-24.06%
-30.6 M INVESTING CASH FLOW
-418.64%
-100 M FINANCING CASH FLOW
-33500.00%
Balance Sheet Decomposition Envista Holdings Corporation
image
Current Assets 1.74 B
Cash & Short-Term Investments 940 M
Receivables 408 M
Other Current Assets 396 M
Non-Current Assets 4.86 B
Long-Term Investments 0
PP&E 435 M
Other Non-Current Assets 4.43 B
Current Liabilities 781 M
Accounts Payable 180 M
Short-Term Debt 176 M
Other Current Liabilities 425 M
Non-Current Liabilities 1.65 B
Long-Term Debt 1.51 B
Other Non-Current Liabilities 142 M
EFFICIENCY
Earnings Waterfall Envista Holdings Corporation
image
Revenue 2.57 B
Cost Of Revenue 1.12 B
Gross Profit 1.45 B
Operating Expenses 1.15 B
Operating Income 31.5 M
Other Expenses 132 M
Net Income -100 M
RATIOS
56.52% GROSS MARGIN
56.52%
1.23% OPERATING MARGIN
1.23%
-3.90% NET MARGIN
-3.90%
-2.40% ROE
-2.40%
-1.52% ROA
-1.52%
1.01% ROIC
1.01%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Envista Holdings Corporation
image
Net Income -100 M
Depreciation & Amortization 163 M
Capital Expenditures -58.2 M
Stock-Based Compensation 30.7 M
Change in Working Capital -108 M
Others 248 M
Free Cash Flow 218 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Envista Holdings Corporation
image
Wall Street analysts predict an average 1-year price target for NVST of $20.3 , with forecasts ranging from a low of $17 to a high of $23 .
NVST Lowest Price Target Wall Street Target
17 USD -17.36%
NVST Average Price Target Wall Street Target
20.3 USD -1.31%
NVST Highest Price Target Wall Street Target
23 USD 11.81%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Envista Holdings Corporation
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
907 K USD 2
3-6 MONTHS
0 USD 0
6-9 MONTHS
50 K USD 1
9-12 MONTHS
Date Value Insider Amount Avg Price
3 months ago
Aug 13, 2024
Bought 506 K USD
Keel Paul A
Chief Executive Officer
+ 30000
16.87 USD
3 months ago
Aug 12, 2024
Bought 401 K USD
Hammes Eric D.
Chief Financial Officer
+ 24532
16.33 USD
1 year ago
Nov 16, 2023
Bought 45.8 USD
Conley Eric
SVP, Orthodontics
+ 2
22.9 USD
1 year ago
Nov 16, 2023
Bought 22.9 USD
Conley Eric
SVP, Orthodontics
+ 1
22.898 USD
1 year ago
Nov 16, 2023
Bought 49.9 K USD
Conley Eric
SVP, Orthodontics
+ 2182
22.89 USD
1 year ago
Nov 08, 2023
Bought 109 K USD
Nance Mark E
General Counsel
+ 5000
21.75 USD
1 year ago
Nov 06, 2023
Bought 19.3 K USD
Aghdaei Amir
Chief Executive Officer
+ 897
21.5 USD
1 year ago
Nov 06, 2023
Bought 15.1 K USD
Aghdaei Amir
Chief Executive Officer
+ 701
21.51 USD
1 year ago
Nov 06, 2023
Bought 12.9 K USD
Aghdaei Amir
Chief Executive Officer
+ 600
21.52 USD
1 year ago
Nov 06, 2023
Bought 168 K USD
Aghdaei Amir
Chief Executive Officer
+ 7802
21.53 USD
1 year ago
Nov 06, 2023
Bought 43.1 K USD
Keller Stephen
Principal Financial Officer
+ 2000
21.53 USD
1 year ago
Feb 28, 2023
Sell 380 K USD
Yu Howard H
Chief Financial Officer
- 10016
37.9 USD
2 years ago
Nov 17, 2022
Sell 24 K USD
Yu Howard H
Chief Financial Officer
- 657
36.55 USD
2 years ago
Apr 18, 2022
Sell 244 K USD
Yu Howard H
Chief Financial Officer
- 5341
45.73 USD
2 years ago
Mar 29, 2022
Sell 196 K USD
Aghdaei Amir
Chief Executive Officer
- 3801
51.5 USD
2 years ago
Mar 18, 2022
Sell 335 K USD
Aghdaei Amir
Chief Executive Officer
- 6737
49.75 USD
2 years ago
Mar 18, 2022
Sell 505 K USD
Reis Mischa
SVP, Strategy & Bus. Dev.
- 10092
50 USD
2 years ago
Mar 18, 2022
Sell 988 K USD
Yu Howard H
Chief Financial Officer
- 19752
50.04 USD
2 years ago
Mar 18, 2022
Sell 243 K USD
Yu Howard H
Chief Financial Officer
- 4786
50.86 USD
2 years ago
Mar 16, 2022
Sell 429 K USD
Aghdaei Amir
Chief Executive Officer
- 8982
47.75 USD
2 years ago
Mar 01, 2022
Sell 141 K USD
Reis Mischa
SVP, Strategy & Bus. Dev.
- 2958
47.83 USD
2 years ago
Mar 01, 2022
Sell 200 K USD
Bludworth Curt W
Chief Human Resources Officer
- 4181
47.83 USD
2 years ago
Feb 25, 2022
Sell 172 K USD
Yu Howard H
Chief Financial Officer
- 3598
47.81 USD
2 years ago
Feb 25, 2022
Sell 204 K USD
Reis Mischa
SVP, Strategy & Bus. Dev.
- 4278
47.71 USD
2 years ago
Feb 25, 2022
Sell 403 K USD
Bludworth Curt W
Chief Human Resources Officer
- 8446
47.71 USD
2 years ago
Feb 25, 2022
Sell 238 K USD
Reis Mischa
SVP, Strategy & Bus. Dev.
- 5009
47.59 USD
2 years ago
Feb 11, 2022
Sell 288 K USD
Reis Mischa
SVP, Strategy & Bus. Dev.
- 6056
47.5 USD
2 years ago
Dec 27, 2021
Sell 1.93 M USD
Aghdaei Amir
Chief Executive Officer
- 41207
46.75 USD
2 years ago
Dec 27, 2021
Sell 313 K USD
Aghdaei Amir
Chief Executive Officer
- 6700
46.76 USD
2 years ago
Dec 27, 2021
Sell 98.3 K USD
Aghdaei Amir
Chief Executive Officer
- 2101
46.77 USD
2 years ago
Dec 27, 2021
Sell 18.7 K USD
Aghdaei Amir
Chief Executive Officer
- 400
46.78 USD
2 years ago
Dec 28, 2021
Sell 324 K USD
Aghdaei Amir
Chief Executive Officer
- 6934
46.75 USD
2 years ago
Dec 28, 2021
Sell 14 K USD
Aghdaei Amir
Chief Executive Officer
- 300
46.76 USD
2 years ago
Dec 28, 2021
Sell 18.7 K USD
Aghdaei Amir
Chief Executive Officer
- 400
46.77 USD
2 years ago
Dec 23, 2021
Sell 451 K USD
Reis Mischa
SVP, Strategy & Bus. Dev.
- 10016
45 USD
2 years ago
Dec 23, 2021
Sell 178 K USD
Yu Howard H
Chief Financial Officer
- 3954
45.07 USD
2 years ago
Dec 23, 2021
Sell 601 K USD
Bludworth Curt W
Chief Human Resources Officer
- 13354
45 USD
2 years ago
Dec 22, 2021
Sell 377 K USD
Aghdaei Amir
Chief Executive Officer
- 8434
44.75 USD
3 years ago
Nov 17, 2021
Sell 6.47 K USD
Kappler Jeffrey
Senior Vice President
- 153
42.3 USD
3 years ago
Nov 17, 2021
Sell 27.8 K USD
Yu Howard H
Chief Financial Officer
- 657
42.3 USD
3 years ago
Nov 15, 2021
Sell 22.1 K USD
Kappler Jeffrey
Senior Vice President
- 511
43.2 USD
3 years ago
Sep 14, 2021
Sell 66.6 K USD
Nance Mark E
General Counsel
- 1515
43.99 USD
3 years ago
Sep 14, 2021
Sell 37.8 K USD
Nance Mark E
General Counsel
- 860
44 USD
3 years ago
Sep 14, 2021
Sell 53.5 K USD
Nance Mark E
General Counsel
- 1215
44.01 USD
3 years ago
Sep 14, 2021
Sell 4.4 K USD
Nance Mark E
General Counsel
- 100
44.02 USD
3 years ago
Sep 14, 2021
Sell 13.2 K USD
Nance Mark E
General Counsel
- 300
44.03 USD
3 years ago
Sep 14, 2021
Sell 4.45 K USD
Nance Mark E
General Counsel
- 101
44.04 USD
3 years ago
Sep 14, 2021
Sell 10.1 K USD
Nance Mark E
General Counsel
- 230
44.06 USD
3 years ago
Sep 02, 2021
Sell 38.7 K USD
Nance Mark E
General Counsel
- 880
43.99 USD
3 years ago
Sep 02, 2021
Sell 4.4 K USD
Nance Mark E
General Counsel
- 100
44.01 USD
3 years ago
Aug 27, 2021
Sell 426 K USD
Reis Mischa
SVP, Strategy & Bus. Dev.
- 10016
42.5 USD
3 years ago
Aug 04, 2021
Sell 2.08 K USD
Kappler Jeffrey
Senior Vice President
- 47
44.25 USD
3 years ago
Aug 03, 2021
Sell 176 USD
Nance Mark E
General Counsel
- 4
44.01 USD
3 years ago
Aug 03, 2021
Sell 4.4 K USD
Nance Mark E
General Counsel
- 100
44.03 USD
3 years ago
Aug 02, 2021
Sell 4.4 K USD
Nance Mark E
General Counsel
- 100
44.04 USD
3 years ago
Aug 03, 2021
Sell 4.41 K USD
Nance Mark E
General Counsel
- 100
44.11 USD
3 years ago
Aug 03, 2021
Sell 4.42 K USD
Nance Mark E
General Counsel
- 100
44.16 USD
3 years ago
Aug 02, 2021
Sell 8.81 K USD
Nance Mark E
General Counsel
- 200
44.05 USD
3 years ago
Jul 16, 2021
Sell 69.6 K USD
Kappler Jeffrey
Senior Vice President
- 1658
42 USD
3 years ago
Jul 16, 2021
Sell 2.48 K USD
Kappler Jeffrey
Senior Vice President
- 59
42 USD
3 years ago
Jun 11, 2021
Sell 645 K USD
Bludworth Curt W
Chief Human Resources Officer
- 14654
44 USD
3 years ago
Jun 11, 2021
Sell 368 K USD
Nance Mark E
General Counsel
- 8358
44.05 USD
3 years ago
Jun 07, 2021
Sell 105 K USD
Bludworth Curt W
Chief Human Resources Officer
- 2467
42.36 USD
3 years ago
Jun 07, 2021
Sell 286 K USD
Bludworth Curt W
Chief Human Resources Officer
- 6740
42.36 USD
3 years ago
May 07, 2021
Sell 711 K USD
Reis Mischa
SVP, Strategy & Bus. Dev.
- 15565
45.67 USD
3 years ago
May 07, 2021
Sell 458 K USD
Reis Mischa
SVP, Strategy & Bus. Dev.
- 9914
46.2 USD
3 years ago
May 07, 2021
Sell 1.58 M USD
Yu Howard H
Chief Financial Officer
- 35021
45.17 USD
3 years ago
May 07, 2021
Sell 103 K USD
Aghdaei Amir
Chief Executive Officer
- 2300
44.84 USD
3 years ago
May 06, 2021
Sell 2.17 M USD
Aghdaei Amir
Chief Executive Officer
- 48405
44.76 USD
3 years ago
May 07, 2021
Sell 1.66 M USD
Aghdaei Amir
Chief Executive Officer
- 36596
45.32 USD
3 years ago
May 03, 2021
Sell 45.9 K USD
Reis Mischa
SVP, Strategy & Bus. Dev.
- 1049
43.73 USD
3 years ago
Apr 07, 2021
Sell 606 K USD
Kappler Jeffrey
Senior Vice President
- 13473
44.95 USD
3 years ago
Apr 07, 2021
Sell 3.08 M USD
Aghdaei Amir
Chief Executive Officer
- 70033
44.03 USD
3 years ago
Apr 07, 2021
Sell 9.22 K USD
Aghdaei Amir
Chief Executive Officer
- 205
45 USD
3 years ago
Apr 07, 2021
Sell 76.6 K USD
Yu Howard H
Chief Financial Officer
- 1702
45 USD
3 years ago
Apr 05, 2021
Sell 1.19 M USD
Aghdaei Amir
Chief Executive Officer
- 28397
41.76 USD
3 years ago
Mar 26, 2021
Sell 186 K USD
Kappler Jeffrey
Senior Vice President
- 4579
40.72 USD
3 years ago
Mar 29, 2021
Sell 576 K USD
Kappler Jeffrey
Senior Vice President
- 13971
41.25 USD
3 years ago
Mar 26, 2021
Sell 27.7 K USD
Aghdaei Amir
Chief Executive Officer
- 680
40.75 USD
3 years ago
Mar 22, 2021
Sell 4.65 M USD
Aghdaei Amir
Chief Executive Officer
- 113948
40.79 USD
3 years ago
Mar 22, 2021
Sell 8.26 K USD
Aghdaei Amir
Chief Executive Officer
- 200
41.3 USD
3 years ago
Mar 22, 2021
Sell 950 K USD
Yu Howard H
Chief Financial Officer
- 23321
40.75 USD
3 years ago
Mar 22, 2021
Sell 45.5 K USD
Yu Howard H
Chief Financial Officer
- 1100
41.39 USD
3 years ago
Feb 12, 2021
Sell 498 K USD
Bludworth Curt W
Chief Human Resources Officer
- 12518
39.78 USD
5 years ago
Sep 20, 2019
Bought 44 K USD
Yu Howard H
SENIOR VICE PRESIDENT, CFO
+ 2000
22 USD
5 years ago
Sep 20, 2019
Bought 22 K USD
Reis Mischa
SENIOR VICE PRESIDENT
+ 1000
22 USD
5 years ago
Sep 20, 2019
Bought 110 K USD
Kappler Jeffrey
SENIOR VICE PRESIDENT
+ 5000
22 USD
5 years ago
Sep 20, 2019
Bought 110 K USD
Eriksson Patrik
SENIOR VICE PRESIDENT
+ 5000
22 USD
5 years ago
Sep 20, 2019
Bought 110 K USD
Bludworth Curt W
SENIOR VICE PRESIDENT, CHRO
+ 5000
22 USD
5 years ago
Sep 20, 2019
Bought 220 K USD
Aghdaei Amir
PRESIDENT AND CEO
+ 10000
22 USD
7. News
Deciphering Envista (NVST) International Revenue Trends Evaluate Envista's (NVST) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance. zacks.com - 1 week ago
Envista Stock Climbs on Q3 Earnings and Revenue Beat, Margins Crash NVST delivers better-than-expected top and bottom-line performance in the third quarter of 2024. zacks.com - 2 weeks ago
Envista Holdings Corporation (NVST) Q3 2024 Earnings Conference Call Transcript Envista Holdings Corporation (NYSE:NVST ) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Amit Bhagwat - VP of IR Paul Keel - CEO Eric Hammes - CFO Conference Call Participants Elizabeth Anderson - Evercore ISI Jeff Johnson - Robert W. Baird & Co. Erin Wright - Morgan Stanley & Co. Jon Block - Stifel, Nicolaus & Company Michael Cherney - Leerink Partners Kevin Caliendo - UBS Securities Brandon Vazquez - William Blair & Company Vivek Chopra - Wells Fargo Operator My name is David and I'll be your conference facilitator this afternoon. seekingalpha.com - 2 weeks ago
Compared to Estimates, Envista (NVST) Q3 Earnings: A Look at Key Metrics Although the revenue and EPS for Envista (NVST) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 2 weeks ago
Envista (NVST) Q3 Earnings and Revenues Beat Estimates Envista (NVST) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.43 per share a year ago. zacks.com - 2 weeks ago
Envista Reports Third Quarter 2024 Results BREA, Calif. , Oct. 30, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the third quarter of 2024. prnewswire.com - 2 weeks ago
Earnings Preview: Envista (NVST) Q3 Earnings Expected to Decline Envista (NVST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 3 weeks ago
Envista Schedules Third Quarter 2024 Earnings Call BREA, Calif. , Oct. 7, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its third quarter 2024 on Wednesday, October 30, 2024. prnewswire.com - 1 month ago
Envista Announces Participation in Baird's 2024 Global Healthcare Conference BREA, Calif. , Aug. 27, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Baird 2024 Global Healthcare Conference on Wednesday, September 11, 2024 from 10:50 – 11:20 am ET at the InterContinental New York Barclay. prnewswire.com - 2 months ago
Envista: $1.2 Billion Asset Impairments Was Fully Priced In Envista Holdings Corporation published Q2 2024 earnings results, highlighting a $1.2 billion non-cash charge from impairments. I find their valuation metrics quite attractive, comparing favorably to both the healthcare sector and their 5-year historical averages. Despite recent challenges, the company continues to generate positive free cash flows. seekingalpha.com - 3 months ago
Why Envista (NVST) International Revenue Trends Deserve Your Attention Examine Envista's (NVST) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock. zacks.com - 3 months ago
Envista (NVST) Q2 Earnings & Revenues Miss, Margins Fall Envista's (NVST) Spark division sales witness a slowdown in the second quarter due to the deferment of a larger portion of case revenues. zacks.com - 3 months ago
8. Profile Summary

Envista Holdings Corporation NVST

image
COUNTRY US
INDUSTRY Medical - Instruments & Supplies
MARKET CAP $ 3.54 B
Dividend Yield 0.00%
Description Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, and Orascoptic brands; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Insignia, AOA, and Spark brands. This segment also offers software packages, which include DTX Studio Implant for treatment planning of dental implants; TX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic to store and access a various clinical patient images. The company's Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, sensors, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Contact Building E, Brea, CA, 92821-6208 https://www.envistaco.com
IPO Date Sept. 18, 2019
Employees 12800
Officers Mr. Stephen Keller Vice President of Investor Relations Mr. Mark E. Nance Senior Vice President, General Counsel & Secretary Mr. Mischa M. Reis Senior Vice President of Strategy & Corporate Development Mr. Andrew Chen Chief Information Officer Mr. Suraj Satpathy Chief Human Resources officer Mr. Eric D. Hammes Chief Financial Officer Paul Sumilas Chief Compliance Officer Mr. Paul A. Keel Chief Executive Officer & Director Mr. Faez Kaabi Vice President, Chief Accounting Officer & Corporate Controller Mr. Filippo Impieri Senior Vice President of Emerging Markets